An 80-year-old woman with myelofibrosis and diffuse mosaic attenuation on chest computed tomography

Mack, 2021, The fetal-to-adult hematopoietic stem cell transition and its role in childhood hematopoietic malignancies, Stem Cell Rev. Rep., 10.1007/s12015-021-10230-x Fan, 2018, Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: mayo Clinic case series of 309 patients, Blood Cancer J., 8, 119, 10.1038/s41408-018-0156-6 Singh, 2017, Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series, Pulm. Circ., 7, 261, 10.1177/2045893217702064 Georgiades, 2002, Typical and atypical presentations of extramedullary hemopoiesis, AJR Am. J. Roentgenol., 179, 1239, 10.2214/ajr.179.5.1791239 Rumi, 2006, Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia, Am. J. Hematol., 81, 124, 10.1002/ajh.20509 Scott, 2008, Polycythaemia rubra vera and myelofibrosis with spinal cord compression, J. Clin. Pathol., 61, 681, 10.1136/jcp.2007.053751 Bowling, 2008, Pulmonary extramedullary hematopoiesis, J. Thorac. Imag., 23, 138, 10.1097/RTI.0b013e31815b89aa Marchiori, 2008, Extramedullary hematopoiesis: findings on computed tomography scans of the chest in 6 patients, J. Bras. Pneumol., 34, 812, 10.1590/S1806-37132008001000009 Dingli, 2001, Unexplained pulmonary hypertension in chronic myeloproliferative disorders, Chest, 120, 801, 10.1378/chest.120.3.801 Weinschenker, 2002, Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement, Am. J. Hematol., 69, 277, 10.1002/ajh.10075 Yang, 2017, Diffuse pulmonary extramedullary hematopoiesis in myelofibrosis diagnosed with technetium-99m sulfur colloid bone marrow scintigraphy and single photon emission computerized tomography/CT, Am. J. Hematol., 92, 323, 10.1002/ajh.24616 Meo, 2008, Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review, Int J Lab Hematol, 30, 425, 10.1111/j.1751-553X.2007.00965.x Song, 2018, Understanding splenomegaly in myelofibrosis: association with molecular pathogenesis, Int. J. Mol. Sci., 19, 898, 10.3390/ijms19030898 Harrison, 2012, JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis, N. Engl. J. Med., 366, 787, 10.1056/NEJMoa1110556 Mascarenhas, 2019, MANIFEST, a phase 2 study of CPI-0610, a bromodomain and extraterminal domain inhibitor (BETi), as monotherapy or "Add-on" to ruxolitinib, in patients with refractory or intolerant advanced myelofibrosis, Blood, 134, 670, 10.1182/blood-2019-127119 Yang, 2018, 99mTc-Sulfur colloid bone marrow scintigraphy in diagnosis of diffuse pulmonary extramedullary hematopoiesis secondary to myelofibrosis, J. Nucl. Med. Technol., 46, 368, 10.2967/jnmt.118.210534